Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug - Wall Street Journal

Wall Street Journal

Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug Wall Street Journal LONDON— AstraZeneca AZN 0.93 % PLC said Monday that the Alzheimer's drug it is codeveloping with Eli Lilly LLY 0.71 % & Co. has received fast-track designation from the U.S. Food and Drug Administration, a status designed to speed up the ... Lilly, AstraZeneca nab fast-track review for BACE inhibitor in Alzheimer'sFierceBiotech Lilly, AstraZeneca Alzheimer's drug fast trackedMarketWatch Eli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE InhibitorStreetInsider.com Reuters -Seeking Alpha -Proactive Investors USA & Canada -iNVEZZ all 12 news articles »

Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug - Wall Street Journal
Read More